NCT04638335View on ClinicalTrials.gov

What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 6, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2022

Conditions
Hepatitis A
Interventions
BIOLOGICAL

Blood test

blood test for Anti-HAV antibodies

Trial Locations (1)

1011

Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne, Switzerland, Lausanne

All Listed Sponsors
lead

University of Lausanne Hospitals

OTHER

NCT04638335 - What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years | Biotech Hunter | Biotech Hunter